AstraZeneca rejects offer from Pfizer - MarketLine Financial Deals

AstraZeneca rejects offer from Pfizer

AstraZeneca rejects offer from Pfizer - MarketLine Financial Deals
AstraZeneca rejects offer from Pfizer
Published Apr 26, 2014
4 pages — Published Apr 26, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Update on May 02, 2014:
Pfizer, Inc., a US-based biopharmaceutical company, has submitted a revised written proposal to AstraZeneca PLC.

  
Source:
Document ID
MA147067_140508
Country
Country
Ticker
PFE=US
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "AstraZeneca rejects offer from Pfizer" Apr 26, 2014. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AstraZeneca-rejects-offer-from-Pfizer-2052-102563>
  
APA:
MarketLine Financial Deals. (2014). AstraZeneca rejects offer from Pfizer Apr 26, 2014. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/AstraZeneca-rejects-offer-from-Pfizer-2052-102563>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.